000 01519 a2200445 4500
005 20250512113734.0
264 0 _c19730130
008 197301s 0 0 eng d
022 _a0019-9567
024 7 _a10.1128/iai.5.3.295-299.1972
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDudding, B A
245 0 0 _aEnteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers.
_h[electronic resource]
260 _bInfection and immunity
_cMar 1972
300 _a295-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdenoviridae
_ximmunology
650 0 4 _aAdministration, Oral
650 0 4 _aAntibodies, Viral
_xanalysis
650 0 4 _aAntibody Formation
650 0 4 _aClinical Trials as Topic
650 0 4 _aComplement Fixation Tests
650 0 4 _aFeces
_xmicrobiology
650 0 4 _aHumans
650 0 4 _aImmunization
650 0 4 _aImmunization Schedule
650 0 4 _aLeukocyte Count
650 0 4 _aMale
650 0 4 _aMilitary Medicine
650 0 4 _aPlacebos
650 0 4 _aTime Factors
650 0 4 _aViral Vaccines
_xadministration & dosage
700 1 _aBartelloni, P J
700 1 _aScott, R M
700 1 _aTop, F H
700 1 _aRussell, P K
700 1 _aBuescher, E L
773 0 _tInfection and immunity
_gvol. 5
_gno. 3
_gp. 295-9
856 4 0 _uhttps://doi.org/10.1128/iai.5.3.295-299.1972
_zAvailable from publisher's website
999 _c4568674
_d4568674